ARMP Earnings
Latest Revenue2.5M
Latest Net Income74.1M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $2.02 | 2.5M | 74.1M | +15.7% | +548.9% |
| Q1 2026 | -$3.16 | 789.0K | -115346000 | +60.7% | -1,655.6% |
| Q4 2025 | -$3.42 | 1.1M | -124298000 | -12.1% | -4,985.7% |
| Q3 2025 | -$0.74 | 1.2M | -26675000 | -61.0% | -393.3% |
| Q2 2025 | -$0.45 | 2.2M | -16295000 | — | -280.0% |
| Q1 2025 | -$0.18 | 491.0K | -6531000 | -49.2% | +73.9% |
| Q4 2024 | $0.07 | 1.2M | 2.6M | -19.2% | +112.7% |
| Q3 2024 | -$0.15 | 3.0M | -5481000 | +142.7% | +82.6% |
| Q2 2024 | $0.25 | 0 | 9.0M | — | — |
| Q1 2024 | -$0.69 | 966.0K | -25021000 | — | — |
| Q4 2023 | -$0.55 | 1.5M | -19847000 | — | — |
| Q3 2023 | -$0.86 | 1.2M | -31161000 | — | — |
Armata Pharmaceuticals (ARMP) — Earnings